当前位置：
X-MOL 学术
›
Genes Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
Genes & Diseases ( IF 6.8 ) Pub Date : 2022-09-14 , DOI: 10.1016/j.gendis.2022.09.001 Zander Schwartz 1, 2 , Piao Zhao 2, 3 , Annie Wang 2 , Guozhi Zhao 2, 3 , Wei Zeng 2 , Yonghui Wang 2, 4 , Hue H Luu 2 , Rex C Haydon 2 , Tong-Chuan He 2, 5 , Russell R Reid 2, 5 , Jason Strelzow 2
Genes & Diseases ( IF 6.8 ) Pub Date : 2022-09-14 , DOI: 10.1016/j.gendis.2022.09.001 Zander Schwartz 1, 2 , Piao Zhao 2, 3 , Annie Wang 2 , Guozhi Zhao 2, 3 , Wei Zeng 2 , Yonghui Wang 2, 4 , Hue H Luu 2 , Rex C Haydon 2 , Tong-Chuan He 2, 5 , Russell R Reid 2, 5 , Jason Strelzow 2
Affiliation
Abstract not available
中文翻译：
工程化无核间充质干细胞 (MSCs)，用于将治疗药物靶向输送至疾病部位
摘要不可用
更新日期：2022-09-14
中文翻译：
工程化无核间充质干细胞 (MSCs)，用于将治疗药物靶向输送至疾病部位
摘要不可用
京公网安备 11010802027423号